“When people see me, they just feel like they have to start jogging,” as one chief nurse practitioner tells CURE when discussing how patients with MPNs can reduce their risk of cardiovascular and thrombotic events.
Videos
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss ways patients can be empowered to receive the best care possible.
this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to negate common clinical trial misperceptions.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss how women of color with breast cancer can learn more about their disease.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss low clinical trial participation in Black patients with breast cancer, and factors that may be contributing.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss racial disparities in breast cancer.
Tian Zhang, MD, MHS, provides an overview of the treatment of patients with non–clear cell renal cell carcinoma.
An overview of the treatment protocol for patients with advanced RCC who are receiving IO/TKI or IO/IO combination therapy.
Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.
Dr Noor Abuhadra discusses the various first-line treatment options for metastatic TNBC, highlighting the importance of PDL1 expression for immunotherapy and germline testing for targeted therapies like PARP inhibitors. Patient Shay Elkins shares her treatment journey, from her initial chemo and immunotherapy to surgical intervention, emphasizing the importance of a collaborative approach with her healthcare team and the supportive role of nursing staff.
A childhood cancer specialist discusses how oncology drug shortages may affect the treatment of children with cancer.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer resources for women of color with breast cancer that can help with emotional support throughout their journey.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to share ways patients can delegate tasks in order to take care of themselves during their cancer journey.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer advice and ways patients can seek support to ensure they are taking care of their mental and emotional health after a breast cancer diagnosis.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to offer background on what exactly resilience during breast cancer is.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to highlight the importance of having difficult conversations with one’s family about a breast cancer diagnosis and its treatment.
In this on-demand webinar series, CURE partnered with TOUCH, The Black Breast Cancer Alliance to discuss mental resilience during one’s breast cancer journey.
This program was possible with support from Bayer.
A comprehensive review of treatment options for patients with metastatic hormone-sensitive prostate cancer.
This program was possible with support from Bayer.
Alicia Morgans, MD, MPH, discusses androgen deprivation therapy and its role in treating prostate cancer.
Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.
Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.
This program was possible with support from Bayer.
A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.
This program was possible with support from Bayer.
Expert perspectives on how clinical trials and real-world evidence contribute to treatment decisions in prostate cancer.
A comprehensive overview of systemic therapies available for the treatment of patients with advanced renal cell carcinoma.
Experts in the field of kidney cancer discuss the risk stratification process for renal cell carcinoma and its effect on prognosis.
An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant.
The notion of ‘time toxicity’ causes patients with stage 4 melanoma to have less available time in their everyday lives because of appointments and treatments.
As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about the differences between genetic and genomic testing in breast cancer care.
As part of its Speaking Out video series, CURE spoke with Marla Sustin, from University Hospitals Seidman Cancer Center, about prognostic and predictive outcomes in breast cancer, and the options available as a result.
Advertisement
Advertisement